Thought Leadership
US FDA Exploring Virtual Advisory Cmtes.; Might Sponsors Want to Wait for In-Person Meetings?
April 1, 2020
Derrick Gingery
Pink Sheet

Axinn partner Chad Landmon was quoted in the Pink Sheet article, "US FDA Exploring Virtual Advisory Cmtes.; Might Sponsors Want to Wait for In-Person Meetings?"

Click here to access the article. A subscription is required.

By using the Axinn, Veltrop & Harkrider LLP website with cookies enabled on your browser, you agree to our use of cookies during your browsing experience. Learn more about our privacy policy.